500 days of somatostatin treatment
Fiora, U.
Minerva Dietologica E Gastroenterologica 36(3): 171-176
1990
ISSN/ISBN: 0391-1993 PMID: 1980728 Document Number: 351912
A group of 11 patients received somatostatin for a minimum period of 30 days. Patients affected by pancreatic fistulae following either chronic and acute pancreatitis of surgery were admitted to the study. Other published reports are not explicit about the possible side-effects of such a long period of full-dose therapy (lasting at least twice the recommended cycle). In this case, having been forced to continue therapy, no significant side-effects were observed and the therapy retained its effectiveness and tolerability up to the end of the study.
Document emailed within 1 workday
Related Documents
Gorden, P.; Comi, R.J.; Maton, P.N.; Go, V.L. 1989: NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut Annals of Internal Medicine 110(1): 35-50Nikou, G.C.; Lygidakis, N.J.; Toubanakis, C.; Pavlatos, S.; Tseleni-Balafouta, S.; Giannatou, E.; Mallas, E.; Safioleas, M. 2005: Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues Hepato-Gastroenterology 52(63): 731-741
Hepburn, M.J.; Dooley, D.P.; Skidmore, P.J.; Ellis, M.W.; Starnes, W.F.; Hasewinkle, W.C. 2004: Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis Archives of Internal Medicine 164(15): 1669-1674
Hofland, L.J. 2003: Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog Journal of Endocrinological Investigation 26(8 Suppl): 8-13
Yoshioka, M. 1986: Elevation of somatostatin content, and reduction of somatostatin release by GABA in rat pancreatic islets Kobe Journal of Medical Sciences 32(1): 27-38
O'Carroll, A.M.; Lolait, S.J.; König, M.; Mahan, L.C. 1993: Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin: 28 Molecular Pharmacology 44(6): 1278
Padberg, W.M.; Morgalla, H.; Buhr, J.; Hild, P.; Schwemmle, K. 1991: Immunosuppressive action of somatostatin and the somatostatin analogue SMS 201-995 and their synergistic effect with low-dose cyclosporine a in organ transplantation Transplantation Proceedings 23(1 Part 1): 348
Whitehouse, I.; Beglinger, C.; Fried, M.; Gyr, K. 1984: The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man Hepato-Gastroenterology 31(5): 227-229
Estève, J.P.; Susini, C.; Vaysse, N.; Gineston, J.L.; Pradayrol, L.; Wunsch, E.; Ribet, A. 1982: Effect of somatostatin 14, as natural and synthetic somatostatin 28 on pentagastrin-stimulated gastric acid and pancreatic secretions in conscious dogs Gastroenterologie Clinique et Biologique 6(6-7): 576-580
Vainas, I.; Koussis, C.; Pazaitou-Panayiotou, K.; Drimonitis, A.; Chrisoulidou, A.; Iakovou, I.; Boudina, M.; Kaprara, A.; Maladaki, A. 2004: Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma Journal of Experimental and Clinical Cancer Research: Cr 23(4): 549-559
Claro, A.; Grill, V.; Efendić, S.; Luft, R. 1977: Studies on the mechanisms of somatostatin action on insulin release. IV. effect of somatostatin on cyclic AMP levels and phosphodiesterase activity in isolated rat pancreatic islets Acta Endocrinologica 85(2): 379-388
Tobal, N.; Roumy, J.; Herault, S.; Fomina, G.; Alferova, I.; Arbeille, P. 2001: Cardiac, cerebral and lower limb hemodynamic changes, during HDT (5 days to 42 d) and space flights (7 days to 6 months) Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 8(1): P53-P54
1984: With different working schedule in a new nursing system. 4 days work--3 days off? Krankenpflege. Soins Infirmiers 77(5): 69-70
Jaquet, P.; Gunz, G.; Saveanu, A.; Barlier, A.; Dufour, H.; Taylor, J.; Dong, J.; Kim, S.; Moreau, J.P.; Culler, M.D. 2005: BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide Journal of Endocrinological Investigation 28(11 Suppl International): 21-27
Koc, E.U.; Ozgur, T.; Yerci, O.; Gurel, S. 2013: Somatostatin receptor 1 (SSTR1) and somatostatin receptor 5 (SSTR5)expression in hepatocellular carcinoma Hepato-Gastroenterology 60(127): 1693-1697
Palnaes Hansen, C.; Hegnhøj, J.; Olsen, O. 1989: Somatostatin treatment of gastrointestinal fistulae Annales Chirurgiae et Gynaecologiae 78(2): 124-126
Vega Sáenz, J.L.; Cosme Jiménez, A.; García Bengoechea, M.; Alzate Sáenz de Heredia, L.F.; López López, P.; Arenas Miravé, J.I. 1993: Somatostatin in the treatment of pancreatic ascites Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 84(4): 273-275
Poston, G.J. 1994: Somatostatin and the treatment of pancreatic cancer Annals of the Royal College of Surgeons of England 76(3): 172-174
Hillenbrand, F. 1982: Treatment of a bile fistula with somatostatin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 53(12): 802-803
Döbrönte, Z.; Stöckert, A.; Végh, G.; Varga, L. 1992: Treatment of carcinoid syndrome with a somatostatin analogue Orvosi Hetilap 133(12): 731-734